fluphenazine depot and haloperidol

fluphenazine depot has been researched along with haloperidol in 57 studies

Research

Studies (57)

TimeframeStudies, this research(%)All Research%
pre-199030 (52.63)18.7374
1990's12 (21.05)18.2507
2000's11 (19.30)29.6817
2010's4 (7.02)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Haffmans, PJ; Hoencamp, E; Jansen, GS1
Sachdev, P; Tang, WM1
Aravagiri, M; Chabert, N; Marder, SR; Van Putten, T; Wirshing, WC1
Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV1
Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG1
McCreadie, RG; Whitehead, A; Wiles, DH1
Gloersen, BA; Inderbitzin, LB; Lewine, RR; McDonald, SC; Rosen, PB; Vidanagama, BP1
Amrung, S; Davis, CM; Fidone, GS; Hernandez, JM; Jann, MW1
Annable, L; Campbell, W; Chouinard, G1
Achkova, P1
Beal, MF; Carr, DB; Fisher, J; Martin, JB1
Simpson, GM; Yadalam, K1
Domino, EF1
Lazarus, A1
Jauregui, J; Kelley, AE; Nadaud, D; Stinus, L1
Marder, SR; Van Putten, T1
James, WA; Pary, R; Tobias, CR; Turns, DM1
Dinan, TG1
Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E1
Ellison, GD; Levin, ED; See, RE1
McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH1
Wistedt, B1
Cookson, JC; Gribbon, D; Kennedy, NM1
Holt, RJ; Zengotita, HE1
Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B1
Bonomo, V; Parisi, R; Rapisarda, V1
Blake, IM; Braddock, LE1
Bourne, RC; Cross, AJ; Gamble, SJ; Waddington, JL1
Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR1
Beal, MF; Martin, JB1
Asarnow, RF; Marder, SR; Van Putten, T1
Bacopoulos, NG; Bustos, G; Redmond, DE; Roth, RH1
Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G1
Waddington, JL1
Hwu, HG; Nakra, BR1
Furukawa, T; Yamada, K1
Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O1
Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N1
Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A1
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD1
Arana, GW; Gerding, LB; Labbate, LA; Measom, MO; Santos, AB1
Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA1
Miller, DD1
Conley, RR; Kelly, DL; Love, RC; McMahon, RP1
Allahham, A; Mainwaring, DE; Marriott, J; Stewart, P1
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M1
McEvoy, JP1
Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B1
Britvić, D; Ille, T; Stanković, Z; Vuković, O1
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R1
Citrome, L; Jaffe, A; Levine, J1
Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I1
Kirk Morton, N; Zubek, D1
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T1

Reviews

6 review(s) available for fluphenazine depot and haloperidol

ArticleYear
Neuroleptic plasma levels.
    Schizophrenia bulletin, 1991, Volume: 17, Issue:2

    Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Perphenazine; Schizophrenia; Thiothixene

1991
Blood levels of neuroleptics: state of the art.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:5 Pt 2

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Mental Disorders; Phenothiazines; Research Design; Thioridazine; Thiothixene

1985
Low-dose treatment strategies.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology

1986
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5 Pt 2

    Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Kinetics; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychotic Disorders; Radioimmunoassay; Radioligand Assay

1984
Dose response of prophylactic antipsychotics.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology

1993
Risks versus benefits of different types of long-acting injectable antipsychotics.
    The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 5

    Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal

2006

Trials

11 trial(s) available for fluphenazine depot and haloperidol

ArticleYear
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1990, Volume: 90, Issue:7

    Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia

1990
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Psychopharmacology, 1990, Volume: 101, Issue:2

    Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia

1990
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1989
Low-dose treatment strategies.
    The Journal of clinical psychiatry, 1986, Volume: 47 Suppl

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology

1986
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 151

    Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia

1987
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    International clinical psychopharmacology, 1986, Volume: 1 Suppl 1

    Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia

1986
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    International clinical psychopharmacology, 1986, Volume: 1 Suppl 1

    Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia

1986
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
    Pharmacopsychiatry, 1985, Volume: 18, Issue:3

    Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia

1985
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Psychopharmacology bulletin, 1984,Winter, Volume: 20, Issue:1

    Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia

1984
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.
    Psychopharmacology, 1995, Volume: 117, Issue:4

    Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1995
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
    International clinical psychopharmacology, 2004, Volume: 19, Issue:4

    Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia

2004

Other Studies

41 other study(ies) available for fluphenazine depot and haloperidol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Lowest effective dose of depot neuroleptics.
    The British journal of psychiatry : the journal of mental science, 1992, Volume: 160

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology

1992
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    The Australian and New Zealand journal of psychiatry, 1992, Volume: 26, Issue:4

    Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Infusions, Intravenous; Male; Neurologic Examination; Ocular Motility Disorders; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology

1992
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Psychotic Disorders

1990
Fluphenazine decanoate: a clinical problem?
    The American journal of psychiatry, 1989, Volume: 146, Issue:1

    Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Schizophrenia; Schizophrenic Psychology

1989
Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
    Psychiatry research, 1989, Volume: 28, Issue:2

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Intellectual Disability; Neurocognitive Disorders; Schizophrenia; Substance Withdrawal Syndrome

1989
[Possibilities for research on the proton-acceptor action of drug preparations].
    Eksperimentalna meditsina i morfologiia, 1987, Volume: 26, Issue:3

    Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dose-Response Relationship, Drug; Electric Conductivity; Fluphenazine; Haloperidol; In Vitro Techniques; Lipid Bilayers; Methods; Methotrimeprazine; Phospholipids; Protons; Solutions

1987
Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
    Neuroscience letters, 1985, Jan-21, Volume: 53, Issue:2

    Topics: Animals; Antipsychotic Agents; beta-Endorphin; Brain Chemistry; Chlorpromazine; Corpus Striatum; Dopamine; Endorphins; Fluphenazine; Haloperidol; Limbic System; Male; Radioimmunoassay; Rats; Rats, Inbred Strains

1985
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
    Psychopharmacology. Supplementum, 1985, Volume: 2

    Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome

1985
Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
    General hospital psychiatry, 1985, Volume: 7, Issue:4

    Topics: Antipsychotic Agents; Benztropine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Middle Aged; Schizophrenia

1985
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
    Biological psychiatry, 1986, Volume: 21, Issue:1

    Topics: Animals; Antipsychotic Agents; Enkephalin, Methionine; Flupenthixol; Fluphenazine; Haloperidol; Male; Nucleus Accumbens; Perphenazine; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei; Sulpiride; Time Factors

1986
Depot neuroleptics for acutely psychotic patients.
    The American journal of psychiatry, 1987, Volume: 144, Issue:8

    Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders

1987
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
    Psychological medicine, 1987, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine

1987
Effects of neuroleptic treatments on peripheral opioid secretion.
    Neuropsychobiology, 1987, Volume: 18, Issue:2

    Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Dibenzothiazepines; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Receptors, Opioid; Schizophrenia

1987
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
    Psychopharmacology, 1988, Volume: 94, Issue:3

    Topics: Animals; Female; Fluphenazine; Haloperidol; Mouth; Movement; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome

1988
Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:1

    Topics: Adult; Blood Coagulation Disorders; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Splenomegaly; Time Factors

1986
Long-acting therapy of schizophrenia.
    Advances in biochemical psychopharmacology, 1985, Volume: 40

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine

1985
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    The British journal of psychiatry : the journal of mental science, 1981, Volume: 139

    Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone

1981
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
    Science (New York, N.Y.), 1983, Apr-29, Volume: 220, Issue:4596

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine

1983
Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
    Neuroscience letters, 1984, Jun-15, Volume: 47, Issue:2

    Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Male; Peptides; Pimozide; Rats; Rats, Inbred Strains; Time Factors

1984
Information processing and neuroleptic response in acute and stabilized schizophrenic patients.
    Psychiatry research, 1984, Volume: 13, Issue:1

    Topics: Adult; Antipsychotic Agents; Cognition; Fluphenazine; Haloperidol; Humans; Male; Pattern Recognition, Visual; Schizophrenia; Schizophrenic Psychology

1984
Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    The Journal of pharmacology and experimental therapeutics, 1982, Volume: 221, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chlorocebus aethiops; Dopamine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Serotonin; Tyrosine 3-Monooxygenase

1982
Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
    The American journal of psychiatry, 1982, Volume: 139, Issue:5

    Topics: Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans

1982
Catatonic-like syndrome during neuroleptic therapy.
    Psychosomatics, 1982, Volume: 23, Issue:7

    Topics: Aged; Catatonia; Female; Fluphenazine; Haloperidol; Humans

1982
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
    Pharmacology, 1982, Volume: 24, Issue:3

    Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine

1982
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
    Hospital & community psychiatry, 1993, Volume: 44, Issue:2

    Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans

1993
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
    Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia

1997
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24 Suppl 4

    Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors

1998
Alcohol dependence and hospitalization in schizophrenia.
    Schizophrenia research, 1999, Jul-27, Volume: 38, Issue:1

    Topics: Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Comorbidity; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Marijuana Abuse; Middle Aged; Patient Readmission; Retrospective Studies; Risk Factors; Schizophrenia; Treatment Refusal

1999
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    International journal of geriatric psychiatry, 2002, Volume: 17, Issue:11

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia

2002
Clozapine and tardive dyskinesia.
    The American journal of psychiatry, 2003, Volume: 160, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Longitudinal Studies; Schizophrenia, Paranoid

2003
Rehospitalization risk with second-generation and depot antipsychotics.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2003, Volume: 15, Issue:1

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome

2003
Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
    International journal of pharmaceutics, 2004, Feb-11, Volume: 270, Issue:1-2

    Topics: Capillary Action; Chemistry, Pharmaceutical; Flow Injection Analysis; Flupenthixol; Fluphenazine; Haloperidol; Infusions, Parenteral; Medroxyprogesterone Acetate; Rheology; Suspensions; Viscosity

2004
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
    Psychiatric services (Washington, D.C.), 2007, Volume: 58, Issue:4

    Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People

2007
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Psychiatria Danubina, 2008, Volume: 20, Issue:1

    Topics: Administration, Oral; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Health Knowledge, Attitudes, Practice; Humans; Long-Term Care; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Yugoslavia

2008
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia

2009
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Schizophrenia research, 2010, Volume: 119, Issue:1-3

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2010
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    L'Encephale, 2013, Volume: 39 Suppl 1

    Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia

2013
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia

2013
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:5

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome

2013